What is the Most Weight You Can Lose on Wegovy?

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, produced an average weight loss of 15% at lower doses and up to 22% at maximum doses in pivotal clinical trials. However, the amount of weight you can lose depends on your unique physiology, adherence to the protocol, and whether your treatment plan is tailored to your genetic makeup. Understanding realistic expectations helps you set achievable goals and stay motivated throughout your weight loss journey.

Average Weight Loss Results From Wegovy Clinical Trials

In the STEP clinical trial program, patients taking semaglutide achieved an average weight loss ranging from 5% to 22% of their starting body weight, depending on the dose and duration of treatment. At the 2.4 mg maintenance dose—the standard prescription strength—most participants lost approximately 15% of their body weight over 68 weeks. This translates to roughly 30–50 pounds for someone starting at 200 pounds, though actual results vary widely between individuals.

Weight loss typically accelerates during the first 12 to 16 weeks as your body adapts to the medication and appetite suppression becomes more pronounced. After month four, the rate of weight loss often plateaus, meaning you may continue losing weight but at a slower pace. This plateau is normal and does not indicate treatment failure; it reflects your body reaching a new metabolic equilibrium while taking the medication.

Factors That Determine How Much Weight You Lose on Semaglutide

Genetic variations significantly influence how your body responds to GLP-1 receptor agonists like semaglutide. Key genetic markers—including variants in the GLP1R, GIPR, FTO, and MC4R genes—affect your baseline appetite, metabolic rate, and insulin sensitivity. PlexusDx Precision Peptide Genetic Test identifies your peptide-pathway predispositions across 14 metabolic pathways and 150+ genetic insights, allowing your provider to match you with the most effective compound and dose strategy from the start.

Lifestyle factors play an equally important role in weight loss outcomes. Patients who combine semaglutide with consistent physical activity, reduced calorie intake, and improved sleep quality typically achieve greater weight loss than those relying on medication alone. Your starting body weight, age, metabolism, and any underlying metabolic conditions also influence the percentage and absolute pounds lost.

Can You Lose More Weight Than Wegovy Clinical Trial Data Shows?

Yes, some patients lose more weight than the average 15–22% range reported in trials, particularly when treatment is optimized for their individual metabolism and combined with lifestyle modifications. Case reports and real-world data suggest that patients with higher starting weights, strong dietary adherence, and regular exercise sometimes achieve 25–30% or greater weight loss over extended periods. However, exceeding the trial averages typically requires sustained effort beyond medication alone.

The ceiling for weight loss on semaglutide varies per person and is partly determined by your genetic predisposition to weight regain and appetite control. PlexusDx compounded semaglutide injections—available in strengths starting at $149 per month—allow for fine-tuned dosing that may optimize results compared to fixed-dose commercial formulations. Your dose may need to go up as your body adapts, but your price remains flat, ensuring access to effective therapy without escalating costs.

Why Personalized Semaglutide Therapy May Outperform Standard Treatment

Compounded semaglutide from licensed 503A compounding pharmacies offers customizable dosing and delivery methods unavailable through commercial brands, enabling providers to match your therapy to your genetic profile and tolerance. PlexusDx serves all 50 states without requiring insurance or membership fees, making precision treatment accessible regardless of your coverage status. The Precision Peptide Genetic Test ($99 add-on after your first month) maps your peptide-pathway genetics to predict which GLP-1 formulation—semaglutide injection, oral semaglutide, tirzepatide, or dual-compound GLP-Squared—will likely produce the best results for your body.

Real-world outcomes suggest that genetically-informed semaglutide therapy, combined with behavioral support and consistent medication adherence, may produce weight loss exceeding population averages. PlexusDx medications are HSA/FSA eligible, reducing out-of-pocket costs for qualified patients. Starting treatment early and maintaining consistent dosing—without worrying about your dose may need to go up - your price won't optimizes—removes barriers to achieving your maximum sustainable weight loss.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is a realistic amount of weight to lose on Wegovy in the first month?

Most patients lose 2–4 pounds in the first month, with weight loss accelerating as the dose increases over the first 12 weeks. The rapid initial loss is driven by appetite suppression and reduced calorie intake rather than medication-induced metabolism changes. PlexusDx compounded semaglutide injections starting at $149/month offer the same active ingredient with personalized dosing flexibility to match your individual response.

Does Wegovy stop working after several months?

Semaglutide does not typically lose effectiveness, but weight loss naturally slows as your body adapts and reaches a lower set-point weight. This plateau is expected and not a sign of medication failure; continued use maintains your weight loss and prevents regain. If weight loss stalls significantly, your provider may recommend genetic testing or dose adjustment—PlexusDx Precision Peptide Genetic Test identifies genetic barriers to further weight loss.

How does PlexusDx compounded semaglutide compare to Wegovy in terms of weight loss?

PlexusDx compounded semaglutide contains identical active ingredient to Wegovy and produces equivalent weight loss outcomes when dosed appropriately. The advantage is lower cost—starting at $149/month versus Wegovy's typical $900–$1,300 monthly price—and customizable dosing that can be fine-tuned to your body's response. All PlexusDx medications come from licensed 503A compounding pharmacies and serve all 50 states without insurance.

Can genetic testing predict how much weight I will lose?

The PlexusDx Precision Peptide Genetic Test identifies genetic variants in GLP1R, GIPR, FTO, and MC4R genes that influence your appetite setpoint and metabolic response to semaglutide and tirzepatide. While the test cannot predict an exact weight loss number, it helps your provider select the compound and dosing strategy most likely to maximize your individual results and minimize time spent on ineffective medications. Testing costs $99 as an add-on after your first month of treatment.

What happens to weight loss if I stop taking semaglutide?

Most patients regain a portion of lost weight within 1–2 years of stopping semaglutide, as appetite hormones return to baseline and metabolic rate increases. Long-term weight management typically requires either continued medication use or sustained lifestyle modifications that become increasingly difficult without pharmacological support. PlexusDx flat monthly pricing—$149/month for compounded semaglutide injection—makes maintenance therapy affordable and accessible over the long term without price escalation.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.